tiprankstipranks
Trending News
More News >
Valerio Therapeutics (FR:ALVIO)
:ALVIO
France Market

Valerio Therapeutics (ALVIO) Income Statement

Compare
0 Followers

Valerio Therapeutics Income Statement

Last quarter (Q2 2025), Valerio Therapeutics's total revenue was €126.00K, an increase of Infinity% from the same quarter last year. In Q2, Valerio Therapeutics's net income was €-208.00K. See Valerio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 1.79M€ 1.80M€ 1.44M€ 4.06M€ 1.78M
Gross Profit
€ 1.28M€ 1.27M€ 929.00K€ 3.69M€ 1.43M
Operating Expenses
€ 17.77M€ 21.55M€ 17.66M€ 8.84M€ -765.00K
Depreciation and Amortization
€ 11.31M€ 1.74M€ 33.00K€ 511.00K€ 654.00K
EBITDA
€ -12.06M€ -18.44M€ -17.04M€ -5.86M€ 2.33M
Operating Income
€ -16.49M€ -20.29M€ -17.11M€ -7.33M€ -8.94M
Other Income/Expenses
€ -7.06M€ -39.00K€ -2.16M€ -255.00K€ 9.66M
Pretax Income
€ -23.55M€ -20.33M€ -19.27M€ -7.58M€ 722.00K
Net Income
€ -23.93M€ -20.34M€ -19.56M€ -5.94M€ 1.09M
Per Share Metrics
Basic EPS
€ -0.16€ -0.15€ -0.18€ -0.07€ 0.01
Diluted EPS
€ -0.16€ -0.15€ -0.18€ -0.07€ 0.01
Weighted Average Shares Outstanding
153.88M 135.63M 105.75M 88.21M 73.15M
Weighted Average Shares Outstanding (Diluted)
153.88M 135.63M 105.75M 88.21M 75.87M
Currency in EUR

Valerio Therapeutics Earnings and Revenue History